These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 1540287)
21. Monomethoxypolyethylene glycol modified allergens. Akerblom E Arb Paul Ehrlich Inst Georg Speyer Haus Ferdinand Blum Inst Frankf A M; 1983; (78):231-9. PubMed ID: 6194750 [No Abstract] [Full Text] [Related]
22. Allergenic products standardization--the role of major allergens. Helm RM; Burks AW Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 1997; (91):164-73. PubMed ID: 9383906 [No Abstract] [Full Text] [Related]
23. Allergen standardization: CREATE principles applied to other purified allergens. Chapman MD; Filep S; Tsay A; Vailes LD; Gadermaier G; Ferreira F; King EM Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess; 2009; 96():21-4; discussion 25. PubMed ID: 20799442 [No Abstract] [Full Text] [Related]
24. The European Union CREATE project: a model for international standardization of allergy diagnostics and vaccines. Chapman MD; Ferreira F; Villalba M; Cromwell O; Bryan D; Becker WM; Fernández-Rivas M; Durham S; Vieths S; van Ree R; J Allergy Clin Immunol; 2008 Nov; 122(5):882-889.e2. PubMed ID: 18762328 [TBL] [Abstract][Full Text] [Related]
25. Skin prick testing in biological standardization of allergenic products. Malling HJ Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 1997; (91):157-63. PubMed ID: 9383905 [No Abstract] [Full Text] [Related]
26. Development of a functional in vitro assay as a novel tool for the standardization of allergen extracts in the human system. Vogel L; Lüttkopf D; Hatahet L; Haustein D; Vieths S Allergy; 2005 Aug; 60(8):1021-8. PubMed ID: 15969682 [TBL] [Abstract][Full Text] [Related]
27. Allergen extracts used for diagnosis and therapy: state of the art of allergen extract standardization. Wahl R; Franke D Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 1992; (85):197-205. PubMed ID: 1540293 [No Abstract] [Full Text] [Related]
28. Molecular design of hybrid tumor necrosis factor-alpha III: polyethylene glycol-modified tumor necrosis factor-alpha has markedly enhanced antitumor potency due to longer plasma half-life and higher tumor accumulation. Tsutsumi Y; Kihira T; Tsunoda S; Kamada H; Nakagawa S; Kaneda Y; Kanamori T; Mayumi T J Pharmacol Exp Ther; 1996 Sep; 278(3):1006-11. PubMed ID: 8819479 [TBL] [Abstract][Full Text] [Related]
29. Carl Prausnitz Memorial Lecture. Suppression of antibody responses by chemically modified antigens. Sehon AH Int Arch Allergy Appl Immunol; 1991; 94(1-4):11-20. PubMed ID: 1937863 [TBL] [Abstract][Full Text] [Related]
30. Will genetically modified foods be allergenic? Taylor SL; Hefle SL J Allergy Clin Immunol; 2001 May; 107(5):765-71. PubMed ID: 11344340 [TBL] [Abstract][Full Text] [Related]
31. [Interleukin 4, total and allergen-specific immunoglobulin E antibodies in the blood of individuals with an atopic constitution]. Paranos S; Pravica V; Bonaci B; Stojković-Mostarica M Srp Arh Celok Lek; 1998; 126(3-4):92-6. PubMed ID: 9863362 [TBL] [Abstract][Full Text] [Related]
32. Allergenicity and immunogenicity of the major mugwort pollen allergen Art v 1 chemically modified by acetylation. Perovic I; Milovanovic M; Stanic D; Burazer L; Petrovic D; Milcic-Matic N; Gafvelin G; van Hage M; Jankov R; Cirkovic Velickovic T Clin Exp Allergy; 2009 Mar; 39(3):435-46. PubMed ID: 19178539 [TBL] [Abstract][Full Text] [Related]
33. Control and standardization of allergens and allergoids in Bulgaria. Guencheva G; Petrunov B Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 1992; (85):127-35; discussion 135-6. PubMed ID: 1540284 [No Abstract] [Full Text] [Related]
34. Two-year double-blind trial of a monomethoxy polyethylene glycol (mPEG) modified grass pollen extract at different dose levels. Schäfer T; Przybilla B; Galosi A; Burow G; Ljungstedt-Pahlman I; Dreborg S; Ring J Ann Allergy; 1992 Apr; 68(4):334-9. PubMed ID: 1558329 [TBL] [Abstract][Full Text] [Related]
35. Regulation of allergen products in Europe: what now?--where next? Rooke MB Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 1997; (91):138-44. PubMed ID: 9383903 [No Abstract] [Full Text] [Related]
36. Mussel adhesive protein mimetic polymers for the preparation of nonfouling surfaces. Dalsin JL; Hu BH; Lee BP; Messersmith PB J Am Chem Soc; 2003 Apr; 125(14):4253-8. PubMed ID: 12670247 [TBL] [Abstract][Full Text] [Related]
37. IgE FAST inhibition: a rapid technique for the standardization of pollen allergen extract potency. Jones LA; Jones RM; Sun JV; Tsay YG; Rock HS; Nicholson P Ann Allergy; 1986 Mar; 56(3):222-5. PubMed ID: 3954162 [TBL] [Abstract][Full Text] [Related]
39. Use of monoclonal antibodies in the standardization of Parietaria judaica allergenic extracts. Afferni C; Pini C; Tinghino R; Palumbo S; Biocca MM; Bruno G; Mari A; Di Felice G Biologicals; 1995 Sep; 23(3):239-47. PubMed ID: 8527125 [TBL] [Abstract][Full Text] [Related]
40. Utility of animal models for predicting human allergenicity. Lehrer SB; McClain S Regul Toxicol Pharmacol; 2009 Aug; 54(3 Suppl):S46-51. PubMed ID: 19186207 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]